X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs WOCKHARDT LTD. - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS WOCKHARDT LTD. NOVARTIS/
WOCKHARDT LTD.
 
P/E (TTM) x 347.8 16.7 2,085.6% View Chart
P/BV x 17.1 1.7 1,006.8% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 NOVARTIS   WOCKHARDT LTD.
EQUITY SHARE DATA
    NOVARTIS
Mar-16
WOCKHARDT LTD.
Mar-16
NOVARTIS/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs9822,000 49.1%   
Low Rs556706 78.8%   
Sales per share (Unadj.) Rs252.9403.7 62.6%  
Earnings per share (Unadj.) Rs62.129.5 210.9%  
Cash flow per share (Unadj.) Rs63.342.4 149.4%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs363.6323.4 112.4%  
Shares outstanding (eoy) m31.96110.51 28.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.03.4 90.7%   
Avg P/E ratio x12.445.9 27.0%  
P/CF ratio (eoy) x12.231.9 38.1%  
Price / Book Value ratio x2.14.2 50.6%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m24,580149,509 16.4%   
No. of employees `0000.87.4 10.2%   
Total wages/salary Rs m1,8019,443 19.1%   
Avg. sales/employee Rs Th10,748.96,048.6 177.7%   
Avg. wages/employee Rs Th2,395.21,280.2 187.1%   
Avg. net profit/employee Rs Th2,641.1441.5 598.2%   
INCOME DATA
Net Sales Rs m8,08344,614 18.1%  
Other income Rs m829970 85.5%   
Total revenues Rs m8,91345,584 19.6%   
Gross profit Rs m2345,038 4.6%  
Depreciation Rs m371,426 2.6%   
Interest Rs m21,012 0.2%   
Profit before tax Rs m1,0253,570 28.7%   
Minority Interest Rs m0-65 0.0%   
Prior Period Items Rs m176 260.9%   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m752255 295.1%   
Profit after tax Rs m1,9863,257 61.0%  
Gross profit margin %2.911.3 25.7%  
Effective tax rate %73.47.1 1,027.9%   
Net profit margin %24.67.3 336.6%  
BALANCE SHEET DATA
Current assets Rs m12,67839,906 31.8%   
Current liabilities Rs m2,43318,423 13.2%   
Net working cap to sales %126.748.2 263.2%  
Current ratio x5.22.2 240.6%  
Inventory Days Days3390 36.3%  
Debtors Days Days2298 22.9%  
Net fixed assets Rs m6935,832 0.2%   
Share capital Rs m160553 28.9%   
"Free" reserves Rs m11,46030,370 37.7%   
Net worth Rs m11,62135,739 32.5%   
Long term debt Rs m016,542 0.0%   
Total assets Rs m14,40079,522 18.1%  
Interest coverage x570.54.5 12,601.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.6 100.1%   
Return on assets %13.85.4 257.2%  
Return on equity %17.19.1 187.6%  
Return on capital %23.68.7 272.5%  
Exports to sales %0.711.6 6.4%   
Imports to sales %18.64.5 416.8%   
Exports (fob) Rs m605,177 1.2%   
Imports (cif) Rs m1,5031,990 75.5%   
Fx inflow Rs m1867,589 2.5%   
Fx outflow Rs m1,8212,878 63.3%   
Net fx Rs m-1,6354,711 -34.7%   
CASH FLOW
From Operations Rs m2,531716 353.4%  
From Investments Rs m-8,270-8,182 101.1%  
From Financial Activity Rs m-3862,543 -15.2%  
Net Cashflow Rs m-6,125-4,923 124.4%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 2.3 87.0%  
FIIs % 1.6 7.7 20.8%  
ADR/GDR % 0.0 0.1 -  
Free float % 21.5 15.4 139.6%  
Shareholders   41,647 67,757 61.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  VENUS REMEDIES  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 18, 2017 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS